Medindia LOGIN REGISTER
Medindia
Advertisement

Law Offices of Howard G. Smith Announces 25 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Micrus Endovascular Corporation

Friday, November 9, 2007 General News
Advertisement
BENSALEM, Pa., Nov. 8 Law Offices of Howard G. Smithannounces a December 3, 2007, deadline to move to be a lead plaintiff in thesecurities class action lawsuit filed on behalf of shareholders who purchasedthe common stock of Micrus Endovascular Corporation ("Micrus" or the"Company")(Nasdaq: MEND) between February 12, 2007 and September 17, 2007,inclusive (the "Class Period"). The shareholder lawsuit is pending in theUnited States District Court for the Southern District of Florida.
Advertisement

The Complaint alleges that defendants violated federal securities laws byissuing material misrepresentations to the market concerning the Company'sbusiness and prospects, thereby artificially inflating the price of Micrussecurities.
Advertisement

No class has yet been certified in the above action. Until a class iscertified, you are not represented by counsel unless you retain one. If youpurchased Micrus shares between February 12, 2007 and September 17, 2007, youhave certain rights, and have until December 3, 2007, to move for LeadPlaintiff status. To be a member of the class you need not take any action atthis time, and you may retain counsel of your choice. If you wish to discussthis action or have any questions concerning this Notice or your rights orinterests with respect to these matters, please contact Howard G. Smith,Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112,Bensalem, Pennsylvania 19020, by telephone at (215)638-4847, Toll-Free at(888)638-4847, by email to [email protected] or visit our website athttp://www.howardsmithlaw.com.

SOURCE Law Offices of Howard G. Smith
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close